Concord Drugs Ltd - CONCORD DRUGS Share Price

Sector: Pharmaceuticals | ISIN: INE858L01010
₹ 36.88 (-0.83%) icon25 Apr, 2024, 12:00:00 AM

Concord Drugs Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 4/25/2024 12:00:00 AM

    ₹ 36.88 -0.31 -0.83
  • Open
  • ₹ 37.19
  • Prev. Close
  • ₹ 37.19
  • Turnover(Lac.)
  • ₹ 1
  • Day's High
  • ₹ 37.19
  • Day's Low
  • ₹ 36.12
  • 52 Week's High
  • ₹ 61.5
  • 52 Week's Low
  • ₹ 25.56
  • Book Value
  • ₹ 35.4
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 36.88
  • P/E
  • 43.9
  • EPS
  • 0.84
  • Divi. Yield
  • 0

Concord Drugs Ltd Corporate Actions

19 Mar , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

06 Feb , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

06 Feb , 2024

12:00 AM

07 Nov , 2023

12:00 AM

07 Nov , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

27 Oct , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

12 Oct , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

12 Sep , 2023

12:00 AM

AGM

Announcement date: 12 Sep , 2023

View Details

07 Sep , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

05 Aug , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

05 Aug , 2023

12:00 AM

09 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

12 Sep , 2023

12:00 AM

BookCloser

View Details

No Record Found


Concord Drugs Ltd News and Update

No Record Found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Concord Drugs Ltd SHAREHOLDING SNAPSHOT
26 April , 2024 | 03:04 AM

PROMOTER - TOTAL55.41%

Indian: 55.41%

Foreign: 0%

NON-PROMOTER - TOTAL 44.59%

Institutions: 0.00%

Non-Institutions: 44.59%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Concord Drugs Ltd FINANCIALS

No Data Available To Display Chart

Concord Drugs Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Concord Drugs Ltd

  • S Nagi Reddy
  • Chairman & Managing Director
  • K Ramchandra Reddy
  • Independent Director
  • Koni Reddy
  • Whole Time Director & CFO
  • S. Nagavenkata Hareesh
  • Independent Director
  • S. Manoj Kumar Reddy
  • Whole-time Director
  • Summela Kasu
  • Independent Director
  • Namratha Nagla
  • Company Sec. & Compli. Officer

Summary

CONCORD DRUGS LIMITED is a public limited company established in 1995, is among the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small volume parenterals, Dry powder ) ,Tissue Bio-Adhesive, tablets, capsules and ophthalmic preparations and Ready-to-fill Pellets.State of the art technology having dedicated manufacturing facilities for Liquid Injections, Dry powder Injections and Ready-to-fill Pellets ensures the highest level of process integrity and product quality.The company started with Finished Pharmaceutical Formulations and then diversified into Ready-to-fill Pellets, to provide our customers with end-to-end solution to their various pharmaceutical product needs to commercial contract drug manufacturing.The company operates a state of the art, cGMP contract manufacturing Formulation-Fill-Finish facility, providing comprehensive pharmaceutical development and manufacturing services for drug products.The company has two manufacturing facilities built to comply with standards stipulated by Regulatory... Read More


Reports by Concord Drugs Ltd


Reports by Concord Drugs Ltd

Company FAQ

No Record Found